Literature DB >> 23453411

Successful use of gentamycin as an antibiotic prophylaxis regimen to reduce the rate of healthcare-associated infections after renal transplantation.

Cely S Abboud1, Maria Daniela Bergamasco, Ercilia Evangelista de Sousa, Eliana de Cássia Zandonadi, Doralice Cortez.   

Abstract

At our institution, we observed an increase in the incidence of healthcare-associated infections (HAI) due to Gram-negative bacilli, including three cases of carbapenem-resistant Klebsiella pneumoniae, among patients who underwent renal transplantation. In addition to strengthening infection control measures, we chose to add gentamycin to the antibiotic prophylaxis regimen of patients undergoing renal transplantation. We assessed the number of HAI occurring within 30 days of renal transplantation during two time periods: (1) the pre-intervention period, between September 2009 and June 2010, and (2) the post-intervention period, between July 2010 and April 2011. The intervention consisted of the addition of gentamycin to the surgical antibiotic prophylaxis regimen. The percentage of patients with HAIs was 31% lower during the post-intervention period (p=0.03), with the greatest reductions observed for urinary tract infections (p=0.024). Carbapenem-resistant K. pneumoniae was not isolated during this period. The investigated patients did not exhibit worsening renal function. Further studies are needed to assess antibiotic prophylaxis in renal transplantation patients at institutions where there is a high prevalence of multidrug-resistant Gram-negative bacteria.
Copyright © 2013 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23453411      PMCID: PMC9427425          DOI: 10.1016/j.bjid.2012.10.016

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


The optimal perioperative antibiotic prophylaxis regimen for renal transplant patients remains to be determined, and prophylaxis should be administered based exclusively on clinical evidence.1, 2 At our institution, the Infection Control team observed an increase in the incidence of healthcare-associated infections (HAI) due to Gram-negative bacilli, including three cases of carbapenem-resistant Klebsiella pneumoniae, among patients who underwent renal transplantation,3, 4 and measures were proposed to reduce the incidence of HAI. The Instituto Dante Pazzanese de Cardiologia, located in São Paulo, is a public university hospital with a capacity of 350 beds for cardiovascular surgeries. Approximately 40 renal transplantation surgeries are performed annually. The Institution has a hospital infection control and prevention program and performs active disease surveillance, following criteria from the Centers for Disease Control and Prevention (CDC). We assessed the number of HAI occurring within 30 days of renal transplantation during two time periods: (1) the pre-intervention period, between September 2009 and June 2010, and (2) the post-intervention period, between July 2010 and April 2011. The intervention consisted of an addition of gentamycin to the surgical antibiotic prophylaxis regimen. This addition was based on the previously determined sensitivity profile of HAI-causing bacteria. Antibiotic prophylaxis was administered during the post-intervention period. This regimen included two doses of gentamycin 2 mg/kg, one at the start of anesthesia and one 24 h later; one dose of cefuroxime 1.5 g at the start of anesthesia; and 750 mg of cefuroxime every 12 h for the next 48 h. Cefuroxime had been previously used at our institution. The characteristics of the patients during the pre- and post-intervention periods are presented in Table 1.
Table 1

Clinical characteristics of the patients during the pre- and post intervention periods.

Characteristics of patientsPre-intervention periodPost-intervention periodp*
N renal TX2421
Average age46.447.5NS
DM 216.7% (4/24)23.8% (5/21)NS
Deceased donor87.5% (21/24)90.5% (19/21)NS
Median length of surgery300 min (5 h)270 min (4 h 30)
Double J70.8% (17/24)71.4% (15/21)NS
Median use of drain13 days10 days
Median of use IC10 days8 days
Death within 30 days8.3% (2/24)4.8% (1/21)NS
HAI rates within 30 days54.2% (13/24)19% (4/12)0.03
Surgical site infection (SSI)16/7% (4/24)9.5% (2/21)0.66
Urinary tract infection (UTI)33.3% (8/24)4.85 (1/21)0.024
Primary bloodstream infection4.2% (1/24)0
Pneumonia04.8% (1/21)

p value-Fischer exact test.

Clinical characteristics of the patients during the pre- and post intervention periods. p value-Fischer exact test. The microorganisms isolated during the pre-intervention period were, 4 Enterobacter spp., 4 Escherichia coli, 1 Proteus mirabilis, 1 multi-sensitive K. pneumoniae and 3 carbapenem-resistant K. pneumonia. In the post-intervention period 1 Enterobacter cloacae, 1 E. coli and 1 multi-sensitive K. pneumoniae were isolated. The percentage of patients with HAIs was 31% lower during the post-intervention period (p = 0.03), with the greatest reductions observed for urinary tract infections (p = 0.024). Carbapenem-resistant K. pneumoniae was not isolated during this period. The investigated patients did not exhibit worsening renal function. The optimal regimen for perioperative antibiotic prophylaxis after renal transplantation remains to be determined. At our institution, we observed an increase in HAI in renal transplantation patients and, in addition to strengthening infection control measures we were encouraged to add gentamycin to the antibiotic prophylaxis regimen of patients undergoing renal transplantation. In the post-intervention period a significant reduction in HAI was observed (p = 0.03), with the greatest reductions observed for urinary tract infections (p = 0.024). Based on these findings, gentamycin was included in the institutional protocol for surgical antibiotic prophylaxis for renal transplantation. A limitation of this study is that only one public hospital in São Paulo was evaluated, such that the sample may not represent the general Brazilian population. Further studies are needed to assess antibiotic prophylaxis in renal transplantation patients. These studies should include a larger number of patients and should be conducted at institutions where there is a high prevalence of multidrug-resistant Gram-negative bacteria.

Conflict of interest

All authors declare to have no conflict of interest.
  4 in total

1.  Surgical antibiotic prophylaxis after renal transplantation: time to reconsider.

Authors:  G Orlando; P Di Cocco; M D'Angelo; K Clemente; T M Manzia; R Angelico; G Tisone; J Romagnoli; F Citterio; A Famulari; F Pisani
Journal:  Transplant Proc       Date:  2010-05       Impact factor: 1.066

2.  Universal perioperative antimicrobial prophylaxis is not necessary in kidney transplantation.

Authors:  Mark R Laftavi; Rezvan Rostami; Sunil Patel; Romesh Kohli; Helia Laftavi; Lin Feng; Meriem Said; Merril Dayton; Oleh Pankewycz
Journal:  Clin Transplant       Date:  2011-10-17       Impact factor: 2.863

3.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

4.  Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.

Authors:  M D Bergamasco; M Barroso Barbosa; D de Oliveira Garcia; R Cipullo; J C M Moreira; C Baia; V Barbosa; C S Abboud
Journal:  Transpl Infect Dis       Date:  2011-10-28       Impact factor: 2.228

  4 in total
  5 in total

Review 1.  Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.

Authors:  Stephanie M Pouch; Michael J Satlin
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

2.  Surgical prophylaxis with gentamicin and acute kidney injury: a systematic review and meta-analysis.

Authors:  Weeraporn Srisung; Jirapat Teerakanok; Pakpoom Tantrachoti; Amputch Karukote; Kenneth Nugent
Journal:  Ann Transl Med       Date:  2017-03

3.  Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.

Authors:  Marcus R Pereira; Brendan F Scully; Stephanie M Pouch; Anne-Catrin Uhlemann; Stella Goudie; Jean E Emond; Elizabeth C Verna
Journal:  Liver Transpl       Date:  2015-12       Impact factor: 5.799

4.  Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.

Authors:  Bingbing Qiao; Jianzhen Wu; Qiquan Wan; Sheng Zhang; Qifa Ye
Journal:  BMC Infect Dis       Date:  2017-02-27       Impact factor: 3.090

5.  Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation.

Authors:  Gemma Sanclemente; Marta Bodro; Carlos Cervera; Laura Linares; Frederic Cofán; Francesc Marco; Jordi Bosch; Federico Oppenheimer; Fritz Dieckmann; Asunción Moreno
Journal:  BMC Nephrol       Date:  2019-07-22       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.